High dose transplantation autologous. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy24

T-Lymphocytes Cells, Cultured Hematopoietic Stem Cells Liver Transplants Antilymphocyte Serum Bone Marrow Cells Bone Marrow Stem Cells T-Lymphocytes, Cytotoxic Kidney Lymphocytes Spleen Dendritic Cells CD4-Positive T-Lymphocytes Killer Cells, Natural Portal Vein CD8-Positive T-Lymphocytes Clone Cells Fetal Blood Mesenchymal Stromal Cells T-Lymphocytes, Regulatory Leukocytes, Mononuclear B-Lymphocytes

Organisms10

Transplantation Chimera Mice, Inbred C57BL Rats, Inbred Lew Mice, Inbred BALB C Rats, Sprague-Dawley Mice, SCID Dogs Rats, Wistar Rabbits Chimera

Diseases43

Graft vs Host Disease Recurrence Postoperative Complications Liver Failure Hematologic Neoplasms Multiple Myeloma Lymphoma, Non-Hodgkin Cadaver Leukemia Acute Disease Liver Diseases Hodgkin Disease Disease Models, Animal Leukemia, Myeloid, Acute Kidney Failure, Chronic Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Neoplasms Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Infection Blood Group Incompatibility Hematologic Diseases Leukemia, Myeloid End Stage Liver Disease Myelodysplastic Syndromes Liver Neoplasms Hepatic Veno-Occlusive Disease Brain Death Liver Cirrhosis Liver Failure, Acute Chronic Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoproliferative Disorders Primary Graft Dysfunction Delayed Graft Function Biliary Atresia Kidney Diseases Carcinoma, Hepatocellular Melanoma Opportunistic Infections Neoplasm Recurrence, Local

Chemicals and Drugs40

Immunosuppressive Agents Melphalan Cyclophosphamide Cyclosporine Busulfan Tacrolimus HLA Antigens Carmustine Myeloablative Agonists Antigens, CD34 Etoposide Antilymphocyte Serum Antibodies, Monoclonal Cytarabine Granulocyte Colony-Stimulating Factor Thiotepa Prednisone Mycophenolic Acid Antineoplastic Agents Vincristine Methylprednisolone Antigens, Neoplasm Interleukin-2 Recombinant Proteins Antigens, CD ABO Blood-Group System Antineoplastic Agents, Alkylating Vidarabine Doxorubicin Isoantibodies Azathioprine Biological Markers Isoantigens Cytokines Dexamethasone Interferon-gamma Antibodies, Neoplasm Prednisolone Cancer Vaccines Cyclosporins

Analytical, Diagnostic and Therapeutic Techniques and Equipment110

Transplantation, Autologous Liver Transplantation Transplantation, Homologous Bone Marrow Transplantation Kidney Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Stem Cell Transplantation Lung Transplantation Transplantation Conditioning Organ Transplantation Blood Transfusion, Autologous Treatment Outcome Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Isogeneic Transplantation, Heterotopic Retrospective Studies Cord Blood Stem Cell Transplantation Combined Modality Therapy Heart-Lung Transplantation Immunosuppression Whole-Body Irradiation Histocompatibility Testing Follow-Up Studies Skin Transplantation Survival Analysis Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Survival Rate Transplantation, Heterologous Remission Induction Antineoplastic Combined Chemotherapy Protocols Tissue Transplantation Corneal Transplantation Disease-Free Survival Bone Marrow Purging Hematopoietic Stem Cell Mobilization Prospective Studies Salvage Therapy Drug Administration Schedule Brain Tissue Transplantation Prognosis Disease Models, Animal Risk Factors Facial Transplantation Organ Preservation Donor Selection Lymphocyte Activation Lymphocyte Culture Test, Mixed Tissue and Organ Harvesting Administration, Oral Neoplasm Transplantation Flow Cytometry Feasibility Studies Postoperative Period Cell Separation Models, Animal Actuarial Analysis Radiation Dosage Lymphocyte Transfusion Lymphocyte Depletion Patient Selection Hand Transplantation Drug Therapy, Combination Biopsy Leukocyte Count Leukapheresis Immunotherapy, Adoptive Immunotherapy Fatal Outcome Double-Blind Method Dose-Response Relationship, Radiation Bone Transplantation Blood Transfusion Cell Culture Techniques Injections, Intravenous Kaplan-Meier Estimate Incidence Immunophenotyping Multivariate Analysis Infusions, Intravenous Immunohistochemistry Anastomosis, Surgical Lethal Dose 50 Blood Cell Count Platelet Count Risk Assessment Colony-Forming Units Assay Postoperative Care Cohort Studies Platelet Transfusion Genetic Therapy Cryopreservation Radiotherapy Dosage Severity of Illness Index Reoperation Coculture Techniques Cell Count Cell- and Tissue-Based Therapy Hepatectomy Cold Ischemia Tissue Engineering Blood Component Removal Treatment Failure Clinical Trials as Topic Pilot Projects

Psychiatry and Psychology1

Phenomena and Processes28

Graft Survival Graft Rejection Transplantation Immunology Time Factors Transplantation Tolerance Histocompatibility Dose-Response Relationship, Drug Lymphocyte Activation Cytotoxicity, Immunologic Cell Differentiation Hematopoiesis Radiation Dosage Immune Tolerance Graft vs Tumor Effect Leukocyte Count Dose-Response Relationship, Radiation Cell Survival Chimerism Graft vs Leukemia Effect Regeneration Lethal Dose 50 Blood Cell Count Platelet Count Cell Proliferation Graft vs Host Reaction Cell Count Immunocompromised Host Immunity, Cellular

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture1

Tissue Engineering

Information Science3

Survival Rate Fatal Outcome Incidence

Named Groups3

Tissue Donors Living Donors Siblings

Health Care30

Treatment Outcome Retrospective Studies Tissue and Organ Procurement Follow-Up Studies Survival Analysis Survival Rate Waiting Lists Disease-Free Survival Prospective Studies Risk Factors Donor Selection Feasibility Studies Postoperative Period Actuarial Analysis Radiation Dosage Patient Selection Fatal Outcome Double-Blind Method Dose-Response Relationship, Radiation Kaplan-Meier Estimate Incidence Multivariate Analysis Risk Assessment Postoperative Care Cohort Studies Age Factors Severity of Illness Index Treatment Failure Clinical Trials as Topic Pilot Projects

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Transplantation, Autologous Liver Transplantation Transplantation, Homologous Bone Marrow Transplantation Kidney Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Stem Cell Transplantation Lung Transplantation Transplantation Conditioning Graft Survival Organ Transplantation Blood Transfusion, Autologous Graft Rejection Treatment Outcome Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Tissue Donors Transplantation Immunology Transplantation Transplantation Chimera Time Factors Immunosuppressive Agents Graft vs Host Disease Peripheral Blood Stem Cell Transplantation Transplantation, Isogeneic Transplantation, Heterotopic Retrospective Studies Living Donors Cord Blood Stem Cell Transplantation Combined Modality Therapy Heart-Lung Transplantation Recurrence Immunosuppression Whole-Body Irradiation Transplantation Tolerance Tissue and Organ Procurement Histocompatibility Testing Follow-Up Studies Melphalan Postoperative Complications Skin Transplantation Cyclophosphamide Survival Analysis Liver Failure Fetal Tissue Transplantation Hematologic Neoplasms Mesenchymal Stem Cell Transplantation Survival Rate Transplantation, Heterologous Remission Induction Antineoplastic Combined Chemotherapy Protocols Tissue Transplantation Multiple Myeloma Cyclosporine T-Lymphocytes Busulfan Waiting Lists Histocompatibility Tacrolimus Lymphoma, Non-Hodgkin Corneal Transplantation Disease-Free Survival Cells, Cultured HLA Antigens Hematopoietic Stem Cells Bone Marrow Purging Carmustine Cadaver Leukemia Hematopoietic Stem Cell Mobilization Prospective Studies Dose-Response Relationship, Drug Salvage Therapy Acute Disease Liver Diseases Myeloablative Agonists Drug Administration Schedule Liver Antigens, CD34 Brain Tissue Transplantation Prognosis Etoposide Hodgkin Disease Disease Models, Animal Risk Factors Facial Transplantation Organ Preservation Donor Selection Transplants Antilymphocyte Serum Antibodies, Monoclonal Mice, Inbred C57BL Cytarabine Bone Marrow Cells Granulocyte Colony-Stimulating Factor Leukemia, Myeloid, Acute Kidney Failure, Chronic Lymphocyte Activation

No FAQ available that match "high dose transplantation autologous"